RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways.

Area of Science:

• Molecular Biology
• Cell Cycle Regulation
• Cancer Biology

Background:

• The retinoblastoma (RB) protein family, including RB1/p105, RBL1/p107, and RBL2/p130, are crucial for cell cycle control, and their dysregulation is linked to cancer.
• While RBL2/p130 is known to be regulated by AKT signaling and involved in apoptosis, the regulatory mechanisms for RBL1/p107 are less understood.

Purpose of the Study:

• To investigate the signaling pathways that regulate the expression and activity of RBL1/p107.
• To elucidate the differences in regulatory mechanisms between RBL1/p107 and its family member RBL2/p130.

Main Methods:

• Investigated the effect of AKT signaling on RBL1/p107 levels.
• Examined the role of calcium (Ca2+)-dependent signaling pathways, specifically calcium/calmodulin-dependent kinases (CaMKs) and calpain, in RBL1/p107 regulation.
• Assessed changes in RBL1/p107 expression, phosphorylation, and nuclear localization upon pathway inhibition.
• Monitored cell cycle progression (G0/G1 arrest).

Main Results:

• AKT signaling had a minor impact on RBL1/p107 levels.
• RBL1/p107 expression and phosphorylation were significantly reduced by CaMKs inhibition, leading to increased nuclear localization and G0/G1 cell cycle arrest.
• Calpain inhibition stabilized RBL1/p107 levels and counteracted the reduction caused by CaMKs inhibition.

Conclusions:

• RBL1/p107 expression is primarily regulated by Ca2+-dependent signaling pathways, involving CaMKs and calpain.
• These findings reveal distinct regulatory mechanisms for RBL1/p107 compared to RBL2/p130, underscoring the complexity of RB protein family regulation in cell cycle control and cancer.